Figure 2From: Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodiesComparison of antigen-binding levels between non-SNA-binding IgG and SNA-binding IgG. A: Comparison of binding levels to MPO, α3(IV)NC1 and PR3 between non-SNA-binding IgG and SNA-binding IgG. Open squares represented non-SNA-binding IgG; Filled squares represented SNA-binding IgG. B: Comparison of binding levels to α3(IV)NC1, EA and EB between non-SNA-binding IgG and SNA-binding IgG. Open squares represented non-SNA-binding IgG; Filled squares represented SNA-binding IgG. C: Influence of neuraminidase treatment on the antigen-binding levels of SNA-binding IgG. Filled squares: before treatment; gray squares: after treatment D: Influence of endoglycosidase F2 treatment on the antigen-binding levels of SNA-binding IgG. Filled squares: before treatment; gray squares: after treatment.Back to article page